Brief: CytoTools Says Marc Herwick Appointed Chief Financial Officer

bioXXmed AG

06/10/2020 08:31

Oct 6 (Reuters) - CytoTools AG  T5OG.DE :
    * SECURES FINANCING OF THE PHASE III STUDY AND APPOINTS
CHIEF
FINANCIAL OFFICER
    * MARC HERWICK APPOINTED CHIEF FINANCIAL OFFICER OF
CYTOTOOLS AG
    * FULL FINANCING OF PHASE III STUDY SECURED AFTER
REGISTRATION OF
CAPITAL INCREASE
    * COMPANY WILL PROVIDE SEPARATE INFORMATION ON START OF
STUDY,
WHICH IS PLANNED FOR Q4 OF 2020.
    * WITHIN FRAMEWORK OF CAPITAL INCREASE, COMPANY RECEIVED
GROSS
PROCEEDS OF EUR 3.7 MILLION

Source text for Eikon:  ID:nEQ5S9WFxa 
Further company coverage:  T5OG.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))